Spero Therapeutics Cash from Investing (TTM) Trends

Spero Therapeutics Inc (SPRO)

1.43 +0.01 (+0.70%) USD | NASDAQ | Apr 25, 16:00

1.435 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	0.00
September 30, 2023	0.00
June 30, 2023	-0.129M
March 31, 2023	49.87M
December 31, 2022	33.81M
September 30, 2022	10.53M
June 30, 2022	27.69M
March 31, 2022	-11.40M
December 31, 2021	7.672M
September 30, 2021	-8.793M
June 30, 2021	-21.87M
March 31, 2021	-14.30M

Date	Value
December 31, 2020	10.47M
September 30, 2020	46.11M
June 30, 2020	26.28M
March 31, 2020	32.64M
December 31, 2019	29.53M
September 30, 2019	40.92M
June 30, 2019	-15.82M
March 31, 2019	-35.66M
December 31, 2018	-83.16M
September 30, 2018	-90.47M
June 30, 2018	-17.85M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-21.87M

Minimum

Jun 2021

49.87M

Maximum

Mar 2023

12.80M

Average

10.47M

Median

Dec 2020

Cash from Investing (TTM) Benchmarks